Review for "Lower Risk of Cardiovascular Events in Patients with Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-world: Results from the SCORE - Clinical ASCVD study"

View at publisher Summarise with VIRAT
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins Heart Failure Treatment and Management

Publication details

Journal / source
Publons reviews and discussion
Publication date
1 January 2026
Language
EN